In last trading session, Citius Oncology Inc (NASDAQ:CTOR) saw 0.29 million shares changing hands with its beta currently measuring 0.08. Company’s recent per share price level of $0.69 trading at -$0.02 or -2.39% at ring of the bell on the day assigns it a market valuation of $49.38M. That closing price of CTOR’s stock is at a discount of -7001.45% from its 52-week high price of $49.00 and is indicating a premium of 20.29% from its 52-week low price of $0.55. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 7.64 million shares which gives us an average trading volume of 1.32 million if we extend that period to 3-months.

Citius Oncology Inc (NASDAQ:CTOR) trade information

Upright in the red during last session for losing -2.39%, in the last five days CTOR remained trading in the green while hitting it’s week-highest on Monday, 03/31/25 when the stock touched $0.69 price level, adding 41.03% to its value on the day. Citius Oncology Inc’s shares saw a change of -39.99% in year-to-date performance and have moved 3.77% in past 5-day. Citius Oncology Inc (NASDAQ:CTOR) showed a performance of -32.34% in past 30-days. Number of shares sold short was 27881.0 shares which calculate 0.54 days to cover the short interests.

1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 5.74M for the same. And 1 analysts are in estimates of company making revenue of 8.6M in the next quarter.

Citius Oncology Inc (NASDAQ:CTOR)’s Major holders

Insiders are in possession of 95.08% of company’s total shares while institution are holding 0.89 percent of that, with stock having share float percentage of 18.10%. Investors also watch the number of corporate investors in a company very closely, which is 0.89% institutions for Citius Oncology Inc that are currently holding shares of the company.